Ernexa Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | $5.3M | $10.9M | $7.2M |
| FY2015 | $7.4M | $3.8M | $3.2M |
| FY2016 | $8.1M | $4.1M | $5.7M |
| FY2017 | $5.1M | $5.5M | $3.4M |
| FY2018 | $3.8M | $6.9M | $2.5M |
| FY2019 | — | $9.7M | $3.2M |
| FY2020 | $532.0K | $7.7M | $777.0K |
| FY2021 | — | $25.5M | $17.0M |
| FY2022 | — | $12.1M | $11.4M |
| FY2023 | — | $2.2M | $7.6M |